Skip to main navigation Skip to search Skip to main content

Drug-Eluting Stent, Drug-Coated Balloon, or Plain Old Balloon Angioplasty for In-Stent Coronary Restenosis: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials

M. Haisum Maqsood, Robert S. Zhang, Nil Rawal, Gal Sella, Neal S. Kleiman, Sripal Bangalore

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: – Drug-coated balloons (DCBs) are now a Food and Drug Administration-approved treatment option for the management of in-stent restenosis (ISR) based on superior outcomes compared with plain old balloon angioplasty (POBA) alone. However, the efficacy of DCB compared with drug-eluting stent (DES; repeat stenting) for ISR is uncertain, with prior studies showing inferiority of DCB. We aimed to compare the outcomes of DES, DCB, or POBA in patients with coronary ISR. METHODS: – We searched PubMed, EMBASE, and https://www.crd.york.ac.uk/PROSPERO; Unique identifier: CRD42024598433.

Original languageEnglish (US)
Pages (from-to)e015161
JournalCirculation: Cardiovascular Interventions
Volume18
Issue number12
DOIs
StatePublished - Dec 2025

Keywords

  • coronary artery disease
  • drug-eluting stents
  • percutaneous coronary intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Drug-Eluting Stent, Drug-Coated Balloon, or Plain Old Balloon Angioplasty for In-Stent Coronary Restenosis: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials'. Together they form a unique fingerprint.

Cite this